HBK Sorce Advisory’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,218
Closed -$232K 433
2018
Q3
$232K Sell
1,218
-125
-9% -$23K 0.03% 346
2018
Q2
$224K Sell
1,343
-461
-26% -$74K 0.03% 350
2018
Q1
$304K Sell
1,804
-265
-13% -$44.5K 0.04% 285
2017
Q4
$339K Sell
2,069
-112
-5% -$20.1K 0.04% 289
2017
Q3
$447K Sell
2,181
-12
-0.5% -$2.79K 0.07% 184
2017
Q2
$533K Sell
2,193
-9
-0.4% -$2.12K 0.09% 161
2017
Q1
$526K Sell
2,202
-145
-6% -$33.8K 0.09% 163
2016
Q4
$493K Sell
2,347
-326
-12% -$67.5K 0.09% 164
2016
Q3
$616K Buy
2,673
+384
+17% +$93.8K 0.12% 127
2016
Q2
$529K Buy
+2,289
New +$528K 0.11% 137

Other funds holding AGN

HBK Sorce Advisory's AGN Position: Q4 2018 in Review

HBK Sorce Advisory sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,218 shares — an estimated $232K sold.

HBK Sorce Advisory first reported a position in AGN in Q2 2016 and held it in 10 quarters. The position peaked at $616K in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • HBK Sorce Advisory reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • HBK Sorce Advisory sold 1,218 Allergan plc shares in Q4 2018, an estimated $232K.
  • HBK Sorce Advisory first reported a position in Allergan plc in Q2 2016 and held it in 10 quarters.
  • HBK Sorce Advisory's Allergan plc position peaked at $616K in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on HBK Sorce Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.